# Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

> **NCT02918539** · — · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 317 (actual)

## Conditions studied

- Alzheimer Disease
- Cognition Disorders

## Interventions

- **DRUG:** florbetapir F 18 PET scan

## Key facts

- **NCT ID:** NCT02918539
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-10-18
- **Final completion:** 2017-10-18
- **Target enrollment:** 317 (ACTUAL)
- **Last updated:** 2018-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918539, "Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT02918539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*